Janssen-Cilag Ltd

50 - 100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG
Telephone: +44 (0)1494 567 567
Fax: +44 (0)1494 567 568
WWW: http://www.janssen-cilag.co.uk
Medical Information Direct Line: +44 (0)800 731 8450
Medical Information e-mail: medinfo@janssen-cilag.co.uk
Customer Care direct line: +44 (0)800 731 5550
Patient Information Leaflet last updated on the eMC: 17/03/2010
PIL Topamax Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/03/2010 and displayed until Current
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to Further Information section
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about missed dose
  • Change to instructions about overdose
  • Change to side-effects
  • Change to drug interactions
  • Change to information about drinking alcohol
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
Updated on 12/02/2009 and displayed until 17/03/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 23/06/2008 and displayed until 12/02/2009
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 22/02/2008 and displayed until 23/06/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to drug interactions
Updated on 20/11/2006 and displayed until 22/02/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about driving or using machinery
  • Change to date of revision
Updated on 17/07/2006 and displayed until 20/11/2006
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to warnings or special precautions for use
Updated on 09/08/2005 and displayed until 17/07/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 26/08/2004 and displayed until 09/08/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 13/08/2004 and displayed until 26/08/2004
Reasons for adding or updating:
  • Change to drug interactions
  • Change to date of revision
Updated on 25/05/2004 and displayed until 13/08/2004
Reasons for adding or updating:
  • Change to side-effects
Updated on 28/01/2004 and displayed until 25/05/2004
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 21/01/2004 and displayed until 28/01/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 29/10/2003 and displayed until 21/01/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 26/09/2003 and displayed until 29/10/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 25/09/2003 and displayed until 26/09/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 09/05/2003 and displayed until 25/09/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 18/06/2002 and displayed until 09/05/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 20/02/2002 and displayed until 18/06/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 01/11/2001 and displayed until 20/02/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 10/10/2001 and displayed until 01/11/2001
Reasons for adding or updating:
  • Update to PIL
Updated on 03/01/2001 and displayed until 10/10/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 27/07/2000 and displayed until 03/01/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   topiramate


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk